Recombinant Capital

Recombinant Capital, widely known as Recap, was a premier business intelligence and consulting firm focused on the biotechnology and pharmaceutical industries. Founded in 1988, the company developed a comprehensive database of life science alliances, licensing agreements, and financial transactions, which became an essential tool for industry benchmarking and valuation. Recap's analysis provided deep insights into deal structures, royalty rates, and market trends for biotech executives and investors. In 2013, the firm was acquired by Deloitte, integrating its specialized data and expertise into Deloitte's Life Sciences practice as Deloitte Recap. The company's legacy continues through its influence on how the industry evaluates and structures complex biopharma partnerships.